Nicholas R. Glover
Independent Non-Executive DirectorDr. Nicholas R. Glover, also known as Nick, Ph.D., serves as Director of PDX Pharmaceuticals, Inc. He serves as an Independent Non-Executive Director of Lite Strategy, Inc. (formerly known as MEI Pharma, Inc.) since June 11, 2013. He serves as Clinical Director and served as Executive Director of Pattern Pharma Inc. He served as Chief Executive Officer, President and Director of Sierra Oncology, Inc. since September 2014 until May 22, 2020 and provided consulting services from July 2014 to August 2014. Dr. Glover served as the President and Chief Executive Officer of YM BioSciences Inc. from November 2010 to February 2013. Dr. Glover served as the Chief Operating Officer of YM BioSciences Inc. from June 7, 2010 to November 2010. He served as President and Chief Executive Officer of Viventia Biotechnologies Inc. from January 8, 2004 to June 2008. He was responsible for all aspects of biotherapeutic development, including GMP manufacturing and has taken products from discovery, through preclinical development and into global registrational clinical trials, with a specific focus in Oncology. He served as Vice President, Corporate Development of Viventia Biotechnologies Inc. since September 2001 until January 8, 2004. Dr. Glover joined Viventia Biotech Inc., in September 2000 and has had responsibility for all aspects of its business development, including financing, corporate partnering and strategic orientation. Dr. Glover has also served as a consultant in the biotechnology and life sciences industries at various times since 2008. Prior to joining Viventia Biotech Inc., he served as an Investment Manager in MDS Capital Corp., where he had responsibilities included sourcing, negotiating and completed venture capital investments in the biotechnology sector. He served as a Director of Viventia Biotechnologies Inc. since June 2004. He has been a Director of YM BioSciences Inc. since November 18, 2010. Dr. Glover holds a B.Sc. (Hons) in Chemistry from the University of East Anglia, U.K., a M.Sc. in Chemistry from the University of British Columbia, Canada and a Ph.D. in Chemistry from Simon Fraser University, Canada.
Positions
- Company NameLite Strategy, Inc.Stock CodeLITSPositionIndependent Non-Executive Director
